You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progressive Malignant Pleural Mesothelioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Pleural Mesothelioma, Advanced Trial in Italy, Switzerland (Lurbinectedin)

Completed
  • Malignant Pleural Mesothelioma, Advanced
  • Alessandria, Italy
  • +7 more
Jul 13, 2021

Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

Active, not recruiting
Has Results
  • Malignant Pleural Mesothelioma
  • Mesothelioma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023

Malignant Pleural Mesothelioma Trial (Proton beam therapy)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Proton beam therapy
  • (no location specified)
Dec 14, 2022

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 16, 2022

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

Recruiting
  • Mesotheliomas Pleural
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023

Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

Recruiting
  • Malignant Pleural Effusion
  • +3 more
  • Leicester, United Kingdom
  • +5 more
Oct 28, 2022

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)

Recruiting
  • Malignant Pleural Mesothelioma
  • E-Nose testing
  • Research blood
  • Basking Ridge, New Jersey
  • +6 more
Sep 8, 2023

Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)

Not yet recruiting
  • Pleural Mesothelioma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 3, 2023

Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National

Not yet recruiting
  • Malignant Pleural Mesotheliomas (Mpm)
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)

Recruiting
  • Malignant Pleural Mesothelioma
  • Chemotherapy Effect
  • hyperthermic intrathoracic chemotherapy
  • Cairo, Egypt
    Ain Shams University hospitals
Aug 18, 2022

Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

Not yet recruiting
  • Pleural Mesothelioma
  • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
  • Rozzano, MI, Italy
  • +5 more
Nov 30, 2023

TTFields in General Routine Clinical Care in Pleural

Not yet recruiting
  • Pleural Mesothelioma
  • TTFields
  • (no location specified)
Sep 9, 2022

Biological Characteristics of Mesothelioma Patients

Completed
  • Malignant Mesothelioma
    • Rozzano, Milano, Italy
    • +1 more
    Sep 8, 2022

    Mesothelioma Trial in Boston (MPT Test, CLDN15/VIM Test)

    Recruiting
    • Mesothelioma
    • MPT Test
    • CLDN15/VIM Test
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Mar 21, 2022

    Mesothelioma; Lung Trial in Toronto (Varying Doses of Background and Boost RT)

    Active, not recruiting
    • Mesothelioma; Lung
    • Varying Doses of Background and Boost RT
    • Toronto, Ontario, Canada
      Princess Margaret Hospital, University Health Network
    Oct 25, 2022

    Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

    Active, not recruiting
    • Cancer
    • +6 more
    • UV1 vaccine + leukine
    • +2 more
    • Perth, Australia
    • +6 more
    Jan 23, 2023

    Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma

    Recruiting
    • Mesothelioma, Malignant
      • Shinjuku-ku, Tokyo, Japan
        Local Institution
      Apr 5, 2022

      Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

      Completed
      • Non Small Cell Lung Cancer (NSCLC)
      • Malignant Pleural Mesothelioma (MPM)
      • Marseille, France
        Assistance Publique des Hôpitaux de Marseille (CEPCM)
      Nov 15, 2022

      Safety of Malignant Pleural Mesothelioma, Treated by

      Completed
      • Malignant Pleural Mesothelioma
      • Data collection
      • Bayonne, France
      • +4 more
      Feb 3, 2022

      Clinical, Radiological and Patient Reported Outcomes After

      Recruiting
      • Pleural Diseases
      • +9 more
      • Pleural interventions
      • Oxford, Oxfordshire, United Kingdom
        Oxford University Hospitals NHS Foundation Trust
      Jun 8, 2023

      Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

      Recruiting
      • Malignant Pleural Mesothelioma
      • Safety
      • Expansion Cohort
      • New York, New York
        Icahn School of Medicine Mount Sinai
      Mar 31, 2022